Palvella Therapeutics PVLA
NASDAQ PVLA
$123.92 +0.96 (+0.78%)
At close: Oct 20, 2026 · 4:00 PM EDT

Palvella Therapeutics (PVLA) Non-Current Debt (2013)

Updated

Palvella Therapeutics' Non-Current Debt was $1.36 million in FY2014.

Analysis

Palvella Therapeutics (PVLA) Non-Current Debt (2013) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non-Current Debt (Qtr)
1 Eli Lilly 1,146.94 Bn 1,115.53 Bn 19.71 Bn 47.86 Bn
2 Johnson & Johnson 624.96 Bn 543.49 Bn 17.26 Bn 37.34 Bn
3 AbbVie 510.15 Bn 483.27 Bn 12.70 Bn 62.48 Bn
4 Merck 366.13 Bn 320.51 Bn 12.21 Bn 51.08 Bn
5 Novartis Ag 297.75 Bn 261.74 Bn 11.24 Bn 1.96 Bn
6 Astrazeneca 261.93 Bn 235.62 Bn 12.86 Bn 23.68 Bn
7 Amgen 236.51 Bn 191.91 Bn 7.24 Bn 51.86 Bn
8 Gilead Sciences 194.27 Bn 168.47 Bn 6.22 Bn 23.83 Bn
9 Pfizer 171.74 Bn 118.39 Bn 10.94 Bn 60.50 Bn
10 Palvella Therapeutics 1.77 Bn 1.52 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2013 1.45 Mn
API Access

Palvella Therapeutics Non-Current Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-current-debt&ticker=PVLA&period=max&api_key=YOUR_API_KEY